{"disease":{"id":"x-linked-lymphoproliferative-disease","name":"x linked lymphoproliferative disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00359411","title":"Genetic Studies of X-linked Lymphoproliferative Disease","phase":"","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03513328","title":"Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of Florida","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}